EP0901471A4 - Antagonistes de la gonadoliberine - Google Patents

Antagonistes de la gonadoliberine

Info

Publication number
EP0901471A4
EP0901471A4 EP97926600A EP97926600A EP0901471A4 EP 0901471 A4 EP0901471 A4 EP 0901471A4 EP 97926600 A EP97926600 A EP 97926600A EP 97926600 A EP97926600 A EP 97926600A EP 0901471 A4 EP0901471 A4 EP 0901471A4
Authority
EP
European Patent Office
Prior art keywords
antagonists
releasing hormone
gonadotropin releasing
gonadotropin
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97926600A
Other languages
German (de)
English (en)
Other versions
EP0901471A1 (fr
Inventor
Mark Goulet
Eric E Allen
Jinlong Jiang
Roy G Smith
Thomas F Walsh
Matthew J Wyvratt Jr
Yi Tien Yang
Jonathan R Young
Robert J Devita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612084.5A external-priority patent/GB9612084D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0901471A1 publication Critical patent/EP0901471A1/fr
Publication of EP0901471A4 publication Critical patent/EP0901471A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP97926600A 1996-05-20 1997-05-16 Antagonistes de la gonadoliberine Withdrawn EP0901471A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1715096P 1996-05-20 1996-05-20
US17150P 1996-05-20
GB9612084 1996-06-10
GBGB9612084.5A GB9612084D0 (en) 1996-06-10 1996-06-10 Antagonists of gonadotropin releasing hormone
PCT/US1997/008479 WO1997044321A1 (fr) 1996-05-20 1997-05-16 Antagonistes de la gonadoliberine

Publications (2)

Publication Number Publication Date
EP0901471A1 EP0901471A1 (fr) 1999-03-17
EP0901471A4 true EP0901471A4 (fr) 1999-08-25

Family

ID=26309477

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97926600A Withdrawn EP0901471A4 (fr) 1996-05-20 1997-05-16 Antagonistes de la gonadoliberine

Country Status (5)

Country Link
EP (1) EP0901471A4 (fr)
JP (1) JP2000511533A (fr)
AU (1) AU706818B2 (fr)
CA (1) CA2254768A1 (fr)
WO (1) WO1997044321A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037326A (en) * 1996-12-31 2000-03-14 Styczynski; Peter Reduction of hair growth
RU2199532C2 (ru) * 1997-06-27 2003-02-27 Фудзисава Фармасьютикал Ко., Лтд. Сульфонамидное соединение
TW436483B (en) * 1997-08-19 2001-05-28 Otsuka Pharma Co Ltd Carbostyril derivatives, process for their preparation and pharmaceutical composition or cosmetic composition for inhibiting skin erythema and/or skin pigmentation
US6346534B1 (en) 1998-09-23 2002-02-12 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US6537998B1 (en) 1999-10-15 2003-03-25 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US6608197B2 (en) 2000-01-25 2003-08-19 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CN1303072C (zh) * 2000-08-31 2007-03-07 霍夫曼-拉罗奇有限公司 7－氧代吡啶并嘧啶
US6583153B2 (en) 2000-12-12 2003-06-24 Ortho-Mcneil Pharmaceutical, Inc. 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
EP1411945A1 (fr) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Pyridin-4-ones substituees et leur utilisation en tant qu'antagonistes du recepteur de l'hormone de liberation de la gonadotrophine
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
AU2002321878A1 (en) 2001-08-02 2003-02-17 Neurocrine Biosciences, Inc. Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
EP1412363A1 (fr) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Antagonistes du recepteur de l'hormone liberatrice de la gonadotropine
JP2005500352A (ja) 2001-08-02 2005-01-06 ニューロクライン バイオサイエンシーズ， インコーポレイテッド ゴナドトロピン放出ホルモンレセプター（ＧｎＲＨ）アンタゴニストとしての１，２，４−トリアジン−３，５−ジオン
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
WO2005049593A2 (fr) * 2003-11-13 2005-06-02 Abbott Laboratories Promoteurs de l'apoptose contenant n-acylsulfonamide
WO2007112347A1 (fr) * 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyl peptidase
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
WO2012175514A1 (fr) 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Dérivés de pyridinone et compositions pharmaceutiques les contenant
CA2958939A1 (fr) 2014-08-26 2016-03-03 Betanien Hospital Methodes, agents et compositions pour le traitement d'etats inflammatoires

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011115A2 (fr) * 1991-11-29 1993-06-10 Merck Sharp & Dohme Limited Derives de quinolone et leur utilisation comme antagonistes des recepteurs de nmda et ampa
WO1995003289A1 (fr) * 1993-07-26 1995-02-02 Merck & Co., Inc. Lactames benzofuses promoteurs de la secretion de l'hormone de croissance
WO1997044339A1 (fr) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonistes de la gonadoliberine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178434A (en) * 1965-04-13 Substituted x-amino-carbostyrils
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011115A2 (fr) * 1991-11-29 1993-06-10 Merck Sharp & Dohme Limited Derives de quinolone et leur utilisation comme antagonistes des recepteurs de nmda et ampa
WO1995003289A1 (fr) * 1993-07-26 1995-02-02 Merck & Co., Inc. Lactames benzofuses promoteurs de la secretion de l'hormone de croissance
WO1997044339A1 (fr) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonistes de la gonadoliberine

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CARLING, ROBERT W. ET AL: "4-Substituted-3-phenylquinolin-2(1H)-ones: Acidic and Nonacidic Glycine Site N-Methyl-D-aspartate Antagonists with in Vivo Activity", J. MED. CHEM. (1997), 40(5), 754-765 CODEN: JMCMAR;ISSN: 0022-2623, XP002105399 *
CHEMICAL ABSTRACTS 8TH COLLECTIVE FORMULA INDEX., COLUMBUS US, XP002105400 *
CHEMICAL ABSTRACTS, vol. 73, no. 15, 12 October 1970, Columbus, Ohio, US; abstract no. 77020w, NISHIMURA, HARUKI ET AL: "Synthesis of 4-hydroxy-2(1H)-quinolone derivatives" XP002105401 *
See also references of WO9744321A1 *
YAKUGAKU ZASSHI (1970), 90(7), 818-28 CODEN: YKKZAJ *

Also Published As

Publication number Publication date
AU3132297A (en) 1997-12-09
AU706818B2 (en) 1999-06-24
JP2000511533A (ja) 2000-09-05
WO1997044321A1 (fr) 1997-11-27
EP0901471A1 (fr) 1999-03-17
CA2254768A1 (fr) 1997-11-27

Similar Documents

Publication Publication Date Title
EP0986385A4 (fr) Antagonistes de gonadoliberine
EP0918522A4 (fr) Antagonistes de la gonadoliberine
IL124554A0 (en) Antagonists of gonadotropin releasing hormone
IL124613A0 (en) Antagonists of gonadotropin releasing hormone
AU3008997A (en) Antagonists of gonadotropin releasing hormone
EP0868178A4 (fr) Antagonistes de la gonadoliberine
EP0986557A4 (fr) Antagonistes de la gonadoliberine
ZA9610535B (en) Antagonists of gonadotropin releasing hormone.
ZA9610536B (en) Antagonists of gonadotropin releasing hormone.
EP1067930A4 (fr) Antagonistes de l'hormone liberant la gonadotropine (gnrh)
EP1011667A4 (fr) Antagonistes de l'hormone de liberation de la gonadotrophine
EP0901471A4 (fr) Antagonistes de la gonadoliberine
EP0920319A4 (fr) Antagonistes de la gonadoliberine
EP1027046A4 (fr) Antagonistes de l'hormone de liberation de la gonadothrophine
EP1049472A4 (fr) Antagonistes de la gonadoliberine
AU4834900A (en) Antagonists of gonadotropin releasing hormone
EP1062215A4 (fr) Antagonistes de l'hormone de liberation de la gonadotrophine
GB9612796D0 (en) Antagonists of gonadotropin releasing hormone
GB9603369D0 (en) Antagonists of gonadotropin releasing hormone
GB9603344D0 (en) Antagonists of gonadotropin releasing hormone
GB9603242D0 (en) Antagonists of gonadotropin releasing hormone
GB9603370D0 (en) Antagonists of gonadotropin releasing hormone
GB9612084D0 (en) Antagonists of gonadotropin releasing hormone
GB9613525D0 (en) Antagonists of gonadotropin releasing hormone
GB9613459D0 (en) Antagonists of gonadotropin releasing hormone

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 07D 215/227 A, 6C 07D 401/12 B, 6A 61K 31/47 B, 6A 61K 31/55 B, 6C 07D 401/06 B, 6C 07D 413/12 B, 6C 07D 215/22 B, 6C 07D 215/46 B, 6C 07D 215/36 B, 6C 07D 453/02 B

A4 Supplementary search report drawn up and despatched

Effective date: 19990713

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20000721

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010201